Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest Coronary stent Stories

2013-10-28 12:25:36

NATICK, Mass., Oct. 28, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will highlight the strength of its advanced portfolio and plans for delivering additional meaningful innovation to clinicians and patients through a robust schedule of sponsored research presentations at the 25(th) Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, October 27 - November 2 in San Francisco. The clinical...

2013-10-28 08:28:49

- Demonstrated Lack of Late Lumen Loss Progression Over 18 Months in Conjunction with Excellent Tissue Healing - DURHAM, N.C., Oct. 28, 2013 /PRNewswire/ -- Micell Technologies, Inc. today announced that imaging and clinical results from the DESSOLVE I and DESSOLVE II trials of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) were presented at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference held in San...

2013-10-26 23:01:57

RnRMarketResearch.com adds Latest Report on “Global Coronary Stents – Market Growth Analysis, 2009-2015” to its store. Global coronary stents industry forecasts to reach at US$7 billion by 2015 at a CAGR of 9.1% during the analysis period 2009-2015. Dallas, TX (PRWEB) October 26, 2013 The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has...

2013-10-23 12:29:59

DUBLIN, October 23, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/p4xrbt/interventional) has announced the addition of the "Interventional Cardiology Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" [http://www.researchandmarkets.com/research/p4xrbt/interventional ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The BRICSS...

2013-10-09 23:20:37

Reportbuyer.com just published a new market research report: Research on China Coronary Stent Industry, 2013-2017 (Update). London (PRWEB) October 09, 2013 The demand for interventional medical core products has increased continuously with the improvement of living quality and the coming of aging society; PCI (percutaneous coronary intervention) surgical cases also increased year by year. In 2012, the usage quantity of coronary stent was about 633,600 sets and the market scale reached CNY...

2013-10-09 20:22:35

MAJESTIC Trial To Study Self-Expanding DES System Designed To Treat Superficial Femoral Artery (SFA) Lesions NATICK, Mass., Oct. 9, 2013 /PRNewswire/ -- Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the Boston Scientific Corporation (NYSE: BSX) Innova(TM) Drug-Eluting Stent (DES) System. The MAJESTIC trial -- designed to evaluate the safety and...

2013-10-08 20:21:57

DUBLIN, October 8, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5w2328/cardiac_medical) has announced the addition of the "Cardiac Medical Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" [http://www.researchandmarkets.com/research/5w2328/cardiac_medical ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) BRICSS Cardiac Medical...

2013-10-01 08:31:13

-- Hefei Life Science will fund and manage clinical development and distribution -- DURHAM, N.C., Oct. 1, 2013 /PRNewswire/ -- Micell Technologies, Inc. has entered into an agreement with Hefei Life Science Technology Park Investment and Development Co., Ltd. (Hefei Life Science), for the clinical development, marketing and distribution of the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®))( )in the People's Republic of China ("PRC"), including...

2013-09-30 08:29:06

-- TCT 2013 presentation of data planned -- DURHAM, N.C., Sept. 30, 2013 /PRNewswire/ -- Micell Technologies, Inc. today announced that a peer reviewed article discussing imaging and clinical results of the DESSOLVE I trial of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) was accepted for publication on the JACC Cardiovascular Interventions website. The paper, "First-in-Human Evaluation of a Bioabsorbable Polymer-Coated Sirolimus-Eluting...

2013-09-24 23:40:13

Barnes-Jewish Hospital is the only hospital in the region implanting a new drug-eluting stent to treat symptomatic blockages of leg arteries caused by peripheral artery disease. St. Louis (PRWEB) September 24, 2013 Although drug-coated stents have been commonly used in coronary procedures, the technology is new to the treatment of peripheral artery disease (PAD). Patrick Geraghty, MD, FACS, Washington University vascular surgeon at Barnes-Jewish Hospital, is the first in the regional area...